Home > Boards > US Listed > Biotechs > Proteostasis Therapeutics (PTI)

* * $PTI Video Chart 06-07-2019 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 8,631
Posts 187,322
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Schedule 13g Edgar (US Regulatory) - 11/8/2019 9:55:40 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:08:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 4:07:22 PM
Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 11/7/2019 4:05:00 PM
Proteostasis Therapeutics Announces Completion of Enrollment in Global Phase 2 Study in Cystic Fibrosis PR Newswire (US) - 11/6/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/1/2019 8:02:11 AM
Proteostasis Therapeutics Announces Presentations Highlighting its CFTR Modulators at the North American Cystic Fibrosis Conf... PR Newswire (US) - 10/24/2019 7:00:00 AM
Proteostasis Therapeutics to Host Cystic Fibrosis Summit on Disparity in Access to CFTR Modulators Based on Geography Featuri... PR Newswire (US) - 10/21/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 8:02:30 AM
Proteostasis Therapeutics to Present at the 2019 Cantor Global Healthcare Conference PR Newswire (US) - 9/26/2019 7:00:00 AM
Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference PR Newswire (US) - 9/19/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/30/2019 4:06:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:08:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:06:44 PM
Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/7/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 5:21:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 4:06:25 PM
Proteostasis Therapeutics Initiates Dosing in Global Phase 2 Study in Cystic Fibrosis PR Newswire (US) - 7/25/2019 7:00:00 AM
Proteostasis Therapeutics Announces Management Changes and Appointments PR Newswire (US) - 7/23/2019 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2019 4:29:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 4:08:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 4:17:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 4:16:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 7:02:20 AM
Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis PR Newswire (US) - 6/4/2019 7:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist